Her main research concerns Cognition, Bipolar disorder, Clinical psychology, Psychiatry and Neuropsychology. She has included themes like Quality of life, Erythropoietin and Mood in her Cognition study. Her studies in Mood integrate themes in fields like Internal medicine and Mood disorders.
Her research in Bipolar disorder intersects with topics in Working memory, Neurocognitive, Verbal learning and Cognitive remediation therapy. Her Clinical psychology research is multidisciplinary, incorporating elements of Young Mania Rating Scale, Clinical trial, Association and Rating scale. The Neuropsychology study combines topics in areas such as Quality of life, Cognitive reserve, Cognitive impairment and Comorbidity.
Kamilla W. Miskowiak mainly investigates Bipolar disorder, Cognition, Clinical psychology, Mood and Psychiatry. Kamilla W. Miskowiak has researched Bipolar disorder in several fields, including Endophenotype, Internal medicine, Randomized controlled trial, Prefrontal cortex and Mood disorders. Her Cognition study deals with the bigger picture of Neuroscience.
Her Clinical psychology research incorporates elements of Facial expression, Cohort and Depression. Her Mood research includes themes of Major depressive disorder, Erythropoietin and Electroconvulsive therapy. The various areas that Kamilla W. Miskowiak examines in her Erythropoietin study include Antidepressant, Anesthesia, Neuroplasticity and Neuroprotection.
Her primary areas of study are Bipolar disorder, Cognition, Clinical psychology, Prefrontal cortex and Neurocognitive. The study incorporates disciplines such as Cognitive skill, Endophenotype, Neuropsychology and Mood in addition to Bipolar disorder. Her Cognition research incorporates themes from Functional magnetic resonance imaging and Mood disorders.
Her study in Clinical psychology is interdisciplinary in nature, drawing from both Cochrane Library, Anxiolytic, Anxiety and Social cognition. Her work carried out in the field of Prefrontal cortex brings together such families of science as Hippocampal formation and Family history. Her research investigates the link between Cognitive remediation therapy and topics such as Randomized controlled trial that cross with problems in Quality of life and Erythropoietin.
Kamilla W. Miskowiak spends much of her time researching Bipolar disorder, Cognition, Clinical psychology, Neurocognitive and Cognitive impairment. Kamilla W. Miskowiak incorporates Bipolar disorder and Monozygotic twin in her studies. While the research belongs to areas of Cognition, Kamilla W. Miskowiak spends her time largely on the problem of Mood disorders, intersecting her research to questions surrounding Prefrontal cortex.
Her Clinical psychology study integrates concerns from other disciplines, such as Emotional intelligence, Social cognition and Endophenotype. Her biological study deals with issues like Facial expression, which deal with fields such as Depression, Infant development and Maternal sensitivity. Her Cognitive impairment research integrates issues from Recall and Cognitive decline.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses
Beatrice Bortolato;Kamilla W Miskowiak;Cristiano A Köhler;Eduard Vieta.
Neuropsychiatric Disease and Treatment (2015)
Cognitive remission: a novel objective for the treatment of major depression?
Beatrice Bortolato;Kamilla W. Miskowiak;Cristiano A. Köhler;Michael Maes;Michael Maes.
BMC Medicine (2016)
Is there an association between subjective and objective measures of cognitive function in patients with affective disorders
Anne M. Svendsen;Lars V. Kessing;Klaus Munkholm;Maj Vinberg.
Nordic Journal of Psychiatry (2012)
Erythropoietin Enhances Hippocampal Response during Memory Retrieval in Humans
Kamilla Miskowiak;Ursula O'Sullivan;Catherine J Harmer.
The Journal of Neuroscience (2007)
Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration
Kamilla Miskowiak;Becky Inkster;Sudhakar Selvaraj;Richard Wise.
Recombinant Human Erythropoietin for Treating Treatment-Resistant Depression: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial
Kamilla W Miskowiak;Maj Vinberg;Ellen M Christensen;Jens D Bukh.
Methodological recommendations for cognition trials in bipolar disorder by the International Society for Bipolar Disorders Targeting Cognition Task Force.
K W Miskowiak;K E Burdick;A Martinez-Aran;C M Bonnin.
Bipolar Disorders (2017)
Screening for cognitive dysfunction in unipolar depression: Validation and evaluation of objective and subjective tools
Caroline Vintergaard Ott;Anne Juul Bjertrup;Johan Høy Jensen;Henrik Ullum.
Journal of Affective Disorders (2016)
Effects of Short-Term Cognitive Remediation on Cognitive Dysfunction in Partially or Fully Remitted Individuals with Bipolar Disorder: Results of a Randomised Controlled Trial
Kirsa M. Demant;Maj Vinberg;Lars V. Kessing;Kamilla W. Miskowiak.
PLOS ONE (2015)
Discrete neurocognitive subgroups in fully or partially remitted bipolar disorder: Associations with functional abilities.
Johan Høy Jensen;Ulla Knorr;Maj Vinberg;Lars V. Kessing.
Journal of Affective Disorders (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: